UnitedHealth Group (UNH, Financial) has been the focal point of attention as Truist Securities made significant adjustments to its price target. On May 19, 2025, analyst David Macdonald from Truist Securities reiterated a "Buy" rating for the stock while simultaneously lowering the price target from $580.00 to $360.00 USD.
This revision represents a substantial decrease of 37.93% from the prior target. Despite the lowered price target, the maintained "Buy" rating reflects ongoing confidence in UnitedHealth Group's long-term prospects.
Investors are advised to consider these changes as they evaluate UNH in their portfolios. The current price target of $360.00 USD is a key figure for stakeholders to monitor moving forward.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 24 analysts, the average target price for UnitedHealth Group Inc (UNH, Financial) is $434.04 with a high estimate of $677.00 and a low estimate of $350.00. The average target implies an upside of 43.67% from the current price of $302.10. More detailed estimate data can be found on the UnitedHealth Group Inc (UNH) Forecast page.
Based on the consensus recommendation from 28 brokerage firms, UnitedHealth Group Inc's (UNH, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for UnitedHealth Group Inc (UNH, Financial) in one year is $703.91, suggesting a upside of 133% from the current price of $302.1036. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the UnitedHealth Group Inc (UNH) Summary page.
